Bullous Pemphigoid Clinical Trial
Official title:
A Retrospective Study of the Effects of Different Pathologic Phenotypes of Bullous Pemphigoid on Clinical Management and Prognosis
Bullous pemphigoid (BP) is a chronic autoimmune subepidermal blistering disease primarily affecting the elderly with a significant risk of mortality and morbidity. Various inflammatory cells such as eosinophils, lymphocytes, neutrophils and their granulopoiesis play an important role in the pathogenesis of BP. Infiltration of peripheral blood eosinophils, lymphocytes, and neutrophils into the skin is considered a major feature of BP, making it a heterogeneous disease with different histologic and clinical subtypes. This clinical study was conducted to further investigate the impact of different pathologic phenotypes of BP on the treatment and prognosis of the disease. A retrospective epidemiologic investigative approach was used，and case collection included demographic information, medical history, clinical manifestations, and histopathologic features. Including gender, age, duration of disease, number of days of hospitalization, mucosal involvement, clinical diagnosis before admission, histopathological diagnosis, laboratory tests, concomitant diseases, treatment and its changes in laboratory indexes before and after treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03286582 -
A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid
|
Phase 2 | |
| Completed |
NCT02837965 -
Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
|
||
| Recruiting |
NCT03636763 -
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
|
||
| Recruiting |
NCT00802243 -
Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid
|
Phase 2 | |
| Completed |
NCT05649579 -
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
|
||
| Active, not recruiting |
NCT04206553 -
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
|
Phase 2/Phase 3 | |
| Completed |
NCT00431119 -
Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid
|
Phase 2 | |
| Completed |
NCT04563923 -
Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
|
Phase 2 | |
| Completed |
NCT03320798 -
Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
|
N/A | |
| Completed |
NCT03272958 -
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
|
||
| Completed |
NCT02883894 -
Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid
|
N/A | |
| Completed |
NCT00809822 -
Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.
|
Phase 2 | |
| Recruiting |
NCT05594472 -
Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid
|
Phase 3 | |
| Withdrawn |
NCT05061771 -
Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
|
Phase 3 | |
| Not yet recruiting |
NCT04128176 -
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
|
Phase 3 | |
| Recruiting |
NCT05284929 -
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
|
||
| Terminated |
NCT04612790 -
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
|
Phase 3 | |
| Recruiting |
NCT05681481 -
A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
|
Phase 3 | |
| Completed |
NCT00286325 -
Rituximab in the Treatment of Patients With Bullous Pemphigoid
|
Phase 1/Phase 2 | |
| Completed |
NCT04728854 -
Telederm and Bullous Pemphigoid
|